Skip to main content
. 2021 Jan 10;10(2):220. doi: 10.3390/jcm10020220

Figure 1.

Figure 1

Prevalence of PIK3CA mutations in cervical carcinomas, HPV+ and HPV– head and neck carcinomas and anal carcinomas. Fisher’s exact test p = 0.01 for the comparison of PIK3CA mutations in HPV+ and HPV– head and neck carcinomas. Data are from TCGA and MSK-IMPACT.